Global and United States Lungs in Vitro Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Lungs in Vitro Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 2D Cell Models
  • 1.2.3 3D Cell Models
  • 1.2.4 Commercial 3D Cell Models
  • 1.2.5 Inhouse 3D Cell Models
• 1.3 Market by Application
  • 1.3.1 Global Lungs in Vitro Market Share by Application: 2020 VS 2026
  • 1.3.2 Drug Screening
  • 1.3.3 Toxicology
  • 1.3.4 3D Model Development
  • 1.3.5 Basic Research
  • 1.3.6 Physiologic Research
  • 1.3.7 Stem Cell Research
  • 1.3.8 Regenerative Medicine
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Lungs in Vitro Market Perspective (2015-2026)
• 2.2 Global Lungs in Vitro Growth Trends by Regions
  • 2.2.1 Lungs in Vitro Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Lungs in Vitro Historic Market Share by Regions (2015-2020)
  • 2.2.3 Lungs in Vitro Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Lungs in Vitro Players by Market Size
  • 3.1.1 Global Top Lungs in Vitro Players by Revenue (2015-2020)
  • 3.1.2 Global Lungs in Vitro Revenue Market Share by Players (2015-2020)
• 3.2 Global Lungs in Vitro Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Lungs in Vitro Revenue
• 3.4 Global Lungs in Vitro Market Concentration Ratio
  • 3.4.1 Global Lungs in Vitro Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Lungs in Vitro Revenue in 2019
• 3.5 Key Players Lungs in Vitro Area Served
• 3.6 Key Players Lungs in Vitro Product Solution and Service
• 3.7 Date of Enter into Lungs in Vitro Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Lungs in Vitro Breakdown Data by Type (2015-2026)

• 4.1 Global Lungs in Vitro Historic Market Size by Type (2015-2020)
• 4.2 Global Lungs in Vitro Forecasted Market Size by Type (2021-2026)

5 Lungs in Vitro Breakdown Data by Application (2015-2026)

• 5.1 Global Lungs in Vitro Historic Market Size by Application (2015-2020)
• 5.2 Global Lungs in Vitro Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Lungs in Vitro Market Size (2015-2026)
• 6.2 North America Lungs in Vitro Market Size by Type (2015-2020)
• 6.3 North America Lungs in Vitro Market Size by Application (2015-2020)
• 6.4 North America Lungs in Vitro Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Lungs in Vitro Market Size (2015-2026)
• 7.2 Europe Lungs in Vitro Market Size by Type (2015-2020)
• 7.3 Europe Lungs in Vitro Market Size by Application (2015-2020)
• 7.4 Europe Lungs in Vitro Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Lungs in Vitro Market Size (2015-2026)
• 8.2 China Lungs in Vitro Market Size by Type (2015-2020)
• 8.3 China Lungs in Vitro Market Size by Application (2015-2020)
• 8.4 China Lungs in Vitro Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Lungs in Vitro Market Size (2015-2026)
• 9.2 Japan Lungs in Vitro Market Size by Type (2015-2020)
• 9.3 Japan Lungs in Vitro Market Size by Application (2015-2020)
• 9.4 Japan Lungs in Vitro Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Lungs in Vitro Market Size (2015-2026)
• 10.2 Southeast Asia Lungs in Vitro Market Size by Type (2015-2020)
• 10.3 Southeast Asia Lungs in Vitro Market Size by Application (2015-2020)
• 10.4 Southeast Asia Lungs in Vitro Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 ATCC
  • 11.1.1 ATCC Company Details
  • 11.1.2 ATCC Business Overview
  • 11.1.3 ATCC Lungs in Vitro Introduction
  • 11.1.4 ATCC Revenue in Lungs in Vitro Business (2015-2020))
  • 11.1.5 ATCC Recent Development
• 11.2 Lonza
  • 11.2.1 Lonza Company Details
  • 11.2.2 Lonza Business Overview
  • 11.2.3 Lonza Lungs in Vitro Introduction
  • 11.2.4 Lonza Revenue in Lungs in Vitro Business (2015-2020)
  • 11.2.5 Lonza Recent Development
• 11.3 Epithelix
  • 11.3.1 Epithelix Company Details
  • 11.3.2 Epithelix Business Overview
  • 11.3.3 Epithelix Lungs in Vitro Introduction
  • 11.3.4 Epithelix Revenue in Lungs in Vitro Business (2015-2020)
  • 11.3.5 Epithelix Recent Development
• 11.4 Mattek
  • 11.4.1 Mattek Company Details
  • 11.4.2 Mattek Business Overview
  • 11.4.3 Mattek Lungs in Vitro Introduction
  • 11.4.4 Mattek Revenue in Lungs in Vitro Business (2015-2020)
  • 11.4.5 Mattek Recent Development
• 11.5 Emulate
  • 11.5.1 Emulate Company Details
  • 11.5.2 Emulate Business Overview
  • 11.5.3 Emulate Lungs in Vitro Introduction
  • 11.5.4 Emulate Revenue in Lungs in Vitro Business (2015-2020)
  • 11.5.5 Emulate Recent Development
• 11.6 Mimetas
  • 11.6.1 Mimetas Company Details
  • 11.6.2 Mimetas Business Overview
  • 11.6.3 Mimetas Lungs in Vitro Introduction
  • 11.6.4 Mimetas Revenue in Lungs in Vitro Business (2015-2020)
  • 11.6.5 Mimetas Recent Development
• 11.7 Tissuse
  • 11.7.1 Tissuse Company Details
  • 11.7.2 Tissuse Business Overview
  • 11.7.3 Tissuse Lungs in Vitro Introduction
  • 11.7.4 Tissuse Revenue in Lungs in Vitro Business (2015-2020)
  • 11.7.5 Tissuse Recent Development
• 11.8 Insphero
  • 11.8.1 Insphero Company Details
  • 11.8.2 Insphero Business Overview
  • 11.8.3 Insphero Lungs in Vitro Introduction
  • 11.8.4 Insphero Revenue in Lungs in Vitro Business (2015-2020)
  • 11.8.5 Insphero Recent Development
• 11.9 Cn Bio
  • 11.9.1 Cn Bio Company Details
  • 11.9.2 Cn Bio Business Overview
  • 11.9.3 Cn Bio Lungs in Vitro Introduction
  • 11.9.4 Cn Bio Revenue in Lungs in Vitro Business (2015-2020)
  • 11.9.5 Cn Bio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer